CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 78 enrolled
Drug / intervention
Spectacles +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03913377
NCT03913377N/ACompleted

Ocular Characteristics in Contact Lens and Spectacle Wear

Johnson & Johnson Vision Care, Inc.·interventional·Posted Apr 12, 2019·Updated Feb 4, 2021

In Brief

A clinical study evaluating Spectacles and ACUVUE OASYS®1-Day with HydraLuxe™ Technology for Visual Acuity. Completed, enrolled 78 participants across 3 sites.

Detailed Summary

This clinical study will investigate the difference in ocular characteristics between contact lens wear and spectacle wear among habitual contact lens wearers, using a 2-treatment by 2-period cross-over design. There will be a 1-week washout between the two study periods to eliminate any potential carryover effect.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsVisual Acuity
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedApr 12, 2019
Enrollment StartApr 9, 2019
Primary CompletionJun 14, 2019
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 7.2 years ago

Interventions

Spectaclesdevice

Subjects' own habitual spectacles

ACUVUE OASYS®1-Day with HydraLuxe™ Technologydevice

Test 1